Literature DB >> 3753749

Decreased free 1,25-dihydroxycholecalciferol index in patients with the nephrotic syndrome.

J Auwerx, L De Keyser, R Bouillon, P De Moor.   

Abstract

The serum concentrations of calcium, phosphorus, parathyroid hormone, vitamin D3 metabolites and their transport protein (DBP) were measured in 18 patients with the nephrotic syndrome (mean daily proteinuria 8.8 g). The glomerular filtration rate was normal in 13 patients while the remaining 5 had a mild degree of renal failure. The serum concentrations of total protein, albumin and DBP were significantly decreased in patients with the nephrotic syndrome. The serum calcium concentration was decreased but the calculated ionized calcium concentration remained normal. The serum concentrations of 25-hydroxycholecalciferol (5.3 +/- 3.1 micrograms/l) and 1,25-dihydroxycholecalciferol [1,25-(OH)2D3 (20 +/- 12 ng/l)] were significantly lower in patients with the nephrotic syndrome and normal glomerular filtration rates than in normal controls (14.4 +/- 4 micrograms/l and 42 +/- 13 ng/l, respectively). The free 1,25-(OH)2D3 index was also significantly below normal (0.9 +/- 0.4 vs. 1.8 +/- 0.4). Total and free 1,25-(OH)2D3 were still further reduced in patients with mild renal failure. The nephrotic syndrome thus results in mild vitamin D depletion with decreased free 1,25-(OH)2D3 concentrations but generally without secondary hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3753749     DOI: 10.1159/000183672

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  9 in total

1.  Is it correct to supplement patients with nephrotic syndrome with vitamin D and calcium?

Authors:  O Mehls
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

2.  Reduced hepatic synthesis of calcidiol in uremia.

Authors:  Josée Michaud; Judith Naud; Denis Ouimet; Christian Demers; Jean-Luc Petit; Francois A Leblond; Alain Bonnardeaux; Marielle Gascon-Barré; Vincent Pichette
Journal:  J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 10.121

3.  Vitamin D status in primary hyperparathyroidism: effect of genetic background.

Authors:  Claudia Battista; Vito Guarnieri; Vincenzo Carnevale; Filomena Baorda; Mauro Pileri; Maria Garrubba; Antonio S Salcuni; Iacopo Chiodini; Salvatore Minisola; Elisabetta Romagnoli; Cristina Eller-Vainicher; Stefano A Santini; Salvatore Parisi; Vincenzo Frusciante; Andrea Fontana; Massimiliano Copetti; Geoffrey N Hendy; Alfredo Scillitani; David E C Cole
Journal:  Endocrine       Date:  2016-05-06       Impact factor: 3.633

Review 4.  Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window.

Authors:  Uwe Querfeld; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2010-06-22       Impact factor: 3.714

Review 5.  Bone Health in Glomerular Kidney Disease.

Authors:  Dorey A Glenn; Michelle R Denburg
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

6.  Vitamin D insufficiency in steroid-sensitive nephrotic syndrome in remission.

Authors:  Francis L Weng; Justine Shults; Rita M Herskovitz; Babette S Zemel; Mary B Leonard
Journal:  Pediatr Nephrol       Date:  2004-11-25       Impact factor: 3.714

7.  Vitamin D metabolites in childhood nephrotic syndrome.

Authors:  A Grymonprez; W Proesmans; M Van Dyck; I Jans; G Goos; R Bouillon
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

8.  Proteomics investigation of the changes in serum proteins after high- and low-flux hemodialysis.

Authors:  Shuai Han; Kaiguang Yang; Hong Zhu; Jianhui Liu; Lihua Zhang; Jiuyang Zhao
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

9.  Association between vitamin D metabolites, vitamin D binding protein, and proteinuria in dogs.

Authors:  Matthew S Miller; Adam J Rudinsky; Brett G Klamer; Dennis J Chew; Valerie J Parker
Journal:  J Vet Intern Med       Date:  2020-10-07       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.